Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL733865 | 0.96 | — | — | |
| SCHEMBL7710475 | 0.89 | — | — | |
| SCHEMBL8384192 | 0.78 | — | — | |
| SCHEMBL8169042 | 0.78 | — | — | |
| SCHEMBL733885 | 0.77 | — | — | |
| SCHEMBL31268401 | 0.77 | CA1 (0.36) | CA1CA2CA4 | |
| SCHEMBL8624272 | 0.77 | — | — | |
| SCHEMBL2265431 | 0.76 | — | — | |
| SCHEMBL733378 | 0.76 | — | — | |
| SCHEMBL4202093 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| WO-2024203438-A1 | CURABLE COMPOSITION | 株式会社カネカ | 2024-10-03 | — | — | WO | disclosed |
| CN-101792550-B | Production process of propylene block copolymer | SUMITOMO CHEMICAL CO | 2014-09-10 | — | — | CN | disclosed |
| CN-103289210-A | Polypropylene resin composition and molded body containing same | SUMITOMO CHEMICAL CO | 2013-09-11 | — | — | CN | disclosed |
| US-8138284-B2 | Process for producing propylene block copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |
| CN-101792550-A | Production process of propylene block copolymer | SUMITOMO CHEMICAL CO | 2010-08-04 | — | — | CN | disclosed |
| CN-101792499-A | Process for producing alpha-olefin polymerization catalyst | SUMITOMO CHEMICAL CO | 2010-08-04 | — | — | CN | disclosed |
| US-20100168349-A1 | PROCESS FOR PRODUCING ALPHA-OLEFIN POLYMERIZATION CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-01 | — | — | US | disclosed |
| US-20100168341-A1 | PROCESS FOR PRODUCING PROPYLENE BLOCK COPOLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022211-A1 | CURABLE COMPOSITION | H1-4, H1-0, H1-2 | CA1 405/4885CA2 1656/4885CA4 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.